Experimental evidence on CD4+ T-cells and AITL patients shows that IDH2 R172 mutations not only lead to an increase in 2-hydroxy-glutarate and hypermethylation of certain promoters but also an increase in H3K27me3 marks [90]. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.